Nanjing Vazyme Biotech Management
Management criteria checks 4/4
Nanjing Vazyme Biotech's CEO is Lin Cao, appointed in May 2020, has a tenure of 4.58 years. directly owns 7.38% of the company’s shares, worth CN¥673.06M. The average tenure of the management team and the board of directors is 4.6 years and 4.6 years respectively.
Key information
Lin Cao
Chief executive officer
CN¥729.9k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.6yrs |
| CEO ownership | 7.4% |
| Management average tenure | 4.6yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Nanjing Vazyme Biotech's (SHSE:688105) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 07
Nanjing Vazyme Biotech Co., Ltd's (SHSE:688105) 45% Price Boost Is Out Of Tune With Revenues
Oct 08Is Nanjing Vazyme BiotechLtd (SHSE:688105) Using Debt In A Risky Way?
Jun 26Nanjing Vazyme Biotech Co.,Ltd's (SHSE:688105) Shares Climb 31% But Its Business Is Yet to Catch Up
Mar 06CEO
Lin Cao (45 yo)
4.6yrs
Tenure
CN¥729,900
Compensation
Mr. Lin Cao is Chairman of the Board and General Manager of Nanjing Vazyme Biotech Co. Ltd from May 2020.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 4.6yrs | CN¥729.90k | 7.38% CN¥ 673.1m | |
| Deputy GM & Director | 4.6yrs | CN¥673.30k | no data | |
| Board Secretary | 4.6yrs | CN¥659.00k | no data | |
| Deputy General Manager | 4.6yrs | CN¥670.20k | no data | |
| Accounting Supervisor | no data | no data | no data |
4.6yrs
Average Tenure
40.5yo
Average Age
Experienced Management: 688105's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 4.6yrs | CN¥729.90k | 7.38% CN¥ 673.1m | |
| Deputy GM & Director | 4.6yrs | CN¥673.30k | no data | |
| Independent Director | 4.6yrs | CN¥150.00k | no data | |
| Independent Director | 4.6yrs | CN¥150.00k | no data | |
| Director | 4.6yrs | CN¥669.30k | no data | |
| Independent Director | 4.3yrs | CN¥150.00k | no data |
4.6yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 688105's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 08:40 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nanjing Vazyme Biotech Co., Ltd is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Yuan Gao | China International Capital Corporation Limited |
| Jin Zhang | China International Capital Corporation Limited |